NANP and malaria: Recently, a SAPN expressing segments of the malaria P. falciparum CSP, the C-terminal structural domain, α-TSR, on the N-terminus, and the central (NANP)6 repeat on the C-terminus was cGMP-produced and advanced to a first in human clinical investigation (FMP014/ALFQ; ClinicalTrials.gov Identifier: NCT04296279).